蔗糖酶-异麦芽糖酶基因功能变异与肠易激综合征风险增加相关
该研究对7个家系病例的SI外显子测序,并在1887例病例对照中筛查4种CSID突变及p.Val15Phe多态性,另在250名一般人群中分析基因型与排便频率和粪便菌群的关系。结果显示CSID突变在患者中更常见(p=0.074;OR=1.84),15Phe增加IBS风险(合并p=0.00012;OR=1.36),且15Phe纯合/剂量与排便频率和Parabacteroides丰度相关,体外酶活性降低35%(p<0.05)。结论认为SI基因变异 predispose to IBS。
要点
- CSID突变在IBS患者中较无症状对照更常见(p=0.074;OR=1.84),较Exome Aggregation Consortium参考测序个体也更常见(p=0.020;OR=1.57)。
- 15Phe等位基因增加IBS风险,腹泻表型证据最强(合并p=0.00012;OR=1.36)。
- 在一般人群中,15Phe等位基因剂量与排便频率(p=0.026)及粪便Parabacteroides丰度(p=0.0024)相关。
核心结论
- SI基因变异编码的蔗糖酶-异麦芽糖酶活性缺陷或降低, predispose to IBS。
- 这可能有助于识别高危个体,并有助于对部分患者进行个体化治疗选择。
研究设计与样本
- 对7个家系病例的SI外显子进行测序,并在1887例病例和对照的多中心队列中筛查4种CSID突变(p.Val557Gly、p.Gly1073Asp、p.Arg1124Ter和p.Phe1745Cys)及常见SI编码多态性p.Val15Phe。
- 体外研究15Val至15Phe替换对SI功能的影响。
- 在250名一般人群个体中分析p.Val15Phe基因型与IBS状态、排便频率和粪便微生物群组成的关系。
主要发现
- CSID突变在患者中较无症状对照更常见(p=0.074;OR=1.84),较Exome Aggregation Consortium参考测序个体也更常见(p=0.020;OR=1.57)。
- 在6/7个测序家系病例中检测到15Phe,且在病例对照和基于人群的队列中增加IBS风险,腹泻表型证据最强(合并p=0.00012;OR=1.36)。
- 在基于人群的样本中,15Phe等位基因剂量与排便频率相关(p=0.026),并与粪便Parabacteroides丰度相关(p=0.0024)。
- 体外实验中,携带15Phe的SI蛋白酶活性较15Val降低35%(p<0.05)。
临床怎么用
- 作者认为SI基因变异编码的蔗糖酶-异麦芽糖酶活性缺陷或降低 predispose to IBS,可能有助于识别高危个体并对部分患者个体化治疗选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: IBS is a common gut disorder of uncertain pathogenesis. Among other factors, genetics and certain foods are proposed to contribute. Congenital sucrase-isomaltase deficiency (CSID) is a rare genetic form of disaccharide malabsorption characterised by diarrhoea, abdominal pain and bloating, which are features common to IBS. We tested sucrase-isomaltase (SI) gene variants for their potential relevance in IBS. DESIGN: We sequenced SI exons in seven familial cases, and screened four CSID mutations (p.Val557Gly, p.Gly1073Asp, p.Arg1124Ter and p.Phe1745Cys) and a common SI coding polymorphism (p.Val15Phe) in a multicentre cohort of 1887 cases and controls. We studied the effect of the 15Val to 15Phe substitution on SI function in vitro. We analysed p.Val15Phe genotype in relation to IBS status, stool frequency and faecal microbiota composition in 250 individuals from the general population. RESULTS: CSID mutations were more common in patients than asymptomatic controls (p=0.074; OR=1.84) and Exome Aggregation Consortium reference sequenced individuals (p=0.020; OR=1.57). 15Phe was detected in 6/7 sequenced familial cases, and increased IBS risk in case-control and population-based cohorts, with best evidence for diarrhoea phenotypes (combined p=0.00012; OR=1.36). In the population-based sample, 15Phe allele dosage correlated with stool frequency (p=0.026) and Parabacteroides faecal microbiota abundance (p=0.0024). The SI protein with 15Phe exhibited 35% reduced enzymatic activity in vitro compared with 15Val (p<0.05). CONCLUSIONS: SI gene variants coding for disaccharidases with defective or reduced enzymatic activity predispose to IBS. This may help the identification of individuals at risk, and contribute to personalising treatment options in a subset of patients.
引用
- Henström M, Diekmann L, Bonfiglio F, et al. Functional variants in the sucrase-isomaltase gene associate with increased risk of irritable bowel syndrome. Gut. 2016. PMID: 27872184. doi:10.1136/gutjnl-2016-312456
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。